MENU

MNPR

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Monopar Therapeutics (MNPR) Ownership - Who owns Monopar Therapeutics?

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company developing a treatment for Wilson disease and novel radiopharmaceuticals for oncology... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

1000 Skokie Boulevard

Phone

+1 847 388-0349

Employees

22

Web

https://www.monopartx.com

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

404.36M

P/E Ratio

N/A

Total Cash

137.49M

Projected Growth

N/A

Total Debt

131.57K

Revenue

N/A

Risk (Beta)

1.53

Dividend Yield

N/A

Total Cash/Share

20.52

Total Debt/Equity

N/A

Revenue/Share

null USD as % of share price

View a ticker or compare two or three

VS

VS

MNPR

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for MNPR

A.I. Advisor

published General Information

General Information

a clinical stage biopharmaceutical company, which engages in building a drug development pipeline of oncology therapeutics in late preclinical and clinical development stages

Industry Biotechnology

Profile

Details

Industry

N/A

Address

1000 Skokie Boulevard

Phone

+1 847 388-0349

Employees

22

Web

https://www.monopartx.com